RYTM: the cashflow

MyFinsight

For the quarter ending 2025-09-30, RYTM had -$83,364K decrease in cash & cash equivalents over the period.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-52,904	-96,130
Stock-based compensation expense	18,810	28,742
Depreciation and amortization	304	762
Non-cash interest expense	4,742	11,226
Non-cash accretion & amortization of short-term investments	-1,695	-2,966
Non-cash rent expense	104	215
Change in fair value of embedded derivative liability	-360	-420
Foreign currency (gain) loss	-1,270	1,709
Accounts receivable	6,600	7,145
Inventory	2,451	96
Prepaid expenses and other current assets	-6,385	10,005
Deferred revenue	0	-1,286
Other long-term assets, net	5,242	-5,526
Accounts payable, accrued expenses and other liabilities	11,015	9,622
Net cash used in operating activities	-26,622	-63,664
Purchases of short-term investments	267,847	60,475
Maturities of short-term investments	61,500	139,322
Acquisition of ipr&d assets	40,000	-
Net cash (used in) provided by investing activities	-246,347	78,847
Repayment of deferred royalty obligation	5,570	8,947
Proceeds from issuance of common stock-Public Offering	188,655	-
Proceeds from the exercise of stock options	5,486	5,669
Proceeds from issuance of common stock from espp	729	854
Proceeds from atm equity offering	-	34,034
Proceeds from issuance of common stock-At Market Offerings	34,035	-
Net cash provided by financing activities	189,301	31,610
Effect of exchange rates on cash	304	-281
Net increase (decrease) in cash, cash equivalents and restricted cash	-83,364	46,512
Cash and cash equivalents at beginning of period	89,601	-
Cash and cash equivalents at end of period	52,749	-

Unit: Thousand (K) dollars